Beijing, China

Songwen Lin

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2018-2025

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: The Innovative Contributions of Inventor Songwen Lin

Introduction

Songwen Lin is a distinguished inventor based in Beijing, China, known for his significant contributions to the field of pharmaceuticals. With a total of four patents to his name, his work primarily focuses on novel compounds and their applications in treating various diseases. His innovative approach and expertise have made him a prominent figure in the research community.

Latest Patents

Songwen Lin's latest patents include groundbreaking developments in benzamide and quinazoline compounds. The first patent, titled "Benzamide compound and preparation method, use, and pharmaceutical composition thereof," introduces a benzamide compound that acts as a STAT3 inhibitor. This compound has promising applications in the prevention and treatment of diseases related to STAT3 activity, including tumors, autoimmune diseases, renal diseases, cardiovascular diseases, inflammation, metabolic/endocrine dysfunction, and neurological diseases.

His second recent patent, "Quinazoline compounds, preparation method, use, and pharmaceutical composition thereof," focuses on quinazoline compounds that serve as phosphatidylinositol 3-kinase (PI3K) inhibitors. These compounds are designed to prevent and treat diseases associated with PI3K activity, such as various cancers, immune diseases, cardiovascular issues, viral infections, inflammation, and metabolic/endocrine dysfunction disorders.

Career Highlights

Throughout his career, Songwen Lin has been affiliated with prestigious institutions such as the Chinese Academy of Sciences and Peking University. His research endeavors at these institutions have been pivotal in advancing the understanding and treatment of complex health conditions through innovative pharmaceutical solutions.

Collaborations

Songwen Lin has collaborated with notable colleagues, including Heng Xu and Xiaoguang Chen. These partnerships have facilitated a productive exchange of ideas and expertise, further enriching the quality and impact of their research outcomes.

Conclusion

As a prolific inventor, Songwen Lin continues to push the boundaries of innovation in the pharmaceutical field. His patents reflect a commitment to addressing critical health challenges through scientific discovery and invention. The implications of his work are vast, holding potential for significant advancements in the prevention and treatment of various diseases. Songwen Lin's contributions are a testament to the power of research and collaboration in driving healthcare innovations forward.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…